A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats

Simona Agostini (1) , Marc Goubern (2) , Valérie Tondereau (3) , Christel Cartier (4) , Valérie Bézirard (3) , Mathilde Lévêque (3) , Hanna Kristina Keranen (1) , Vassilia Theodorou (3) , S. Bourdu-Naturel (2) , N. Goupil-Feuillerat (2) , Sophie Legrain-Raspaud (2) , Hélène Eutamène (3)

1 ToxAlim - ToxAlim
2 Groupe DANONE
3 ToxAlim-NGN - Neuro-Gastroentérologie & Nutrition
4 ToxAlim-ENTeRisk - Endocrinologie & Toxicologie de la Barrière Intestinale

Mots clés: fermented milk; gut barrier; irritable bowel syndrome; pain; probiotics; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL GASTROINTESTINAL DISORDERS; LIGHT-CHAIN KINASE; DOUBLE-BLIND; INTESTINAL PERMEABILITY; LACTOBACILLUS-PARACASEI; COLORECTAL DISTENSION; ANIMALIS DN-173-010; EPITHELIAL BARRIER; PROBIOTIC THERAPY

Domaines: Sciences du Vivant [q-bio]

Simona Agostini, Marc Goubern, Valérie Tondereau, Christel Cartier, Valérie Bézirard, et al.. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Journal of Neurogastroenterology and Motility, 2012, 24 (4), pp.376-e172. ⟨10.1111/j.1365-2982.2011.01865.x⟩. ⟨hal-02647049⟩